PICSTAT Pilot Study for CD8 PET/CT-Guided Lifileucel Treatment in Advanced Melanoma
Conditions
- Unresectable or Metastatic Melanoma
Interventions
- PROCEDURE: Resection of PET (high) and PET (low) Tumors
- BIOLOGICAL: Lifileucel Manufacturing Clinical v Research
- DRUG: Chemotherapy Regimen
- BIOLOGICAL: Lifileucel Infusion
- DRUG: IL-2
- PROCEDURE: CD8 PET
Sponsor
Abramson Cancer Center at Penn Medicine
Collaborators